These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28429555)

  • 1. Management of mineral and bone disorders in renal transplant recipients.
    Damasiewicz MJ; Ebeling PR
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():65-69. PubMed ID: 28429555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKD-mineral and bone disorder management in kidney transplant recipients.
    Alshayeb HM; Josephson MA; Sprague SM
    Am J Kidney Dis; 2013 Feb; 61(2):310-25. PubMed ID: 23102732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the patient with transplantation-related bone loss.
    Ebeling PR
    J Clin Endocrinol Metab; 2009 May; 94(5):1483-90. PubMed ID: 19420272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Mineral Disease After Kidney Transplantation.
    Torregrosa JV; Ferreira AC; Cucchiari D; Ferreira A
    Calcif Tissue Int; 2021 Apr; 108(4):551-560. PubMed ID: 33765230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients.
    Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC
    Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin blood levels before and after kidney transplantation.
    Bonani M; Rodriguez D; Fehr T; Mohebbi N; Brockmann J; Blum M; Graf N; Frey D; Wüthrich RP
    Kidney Blood Press Res; 2014; 39(4):230-9. PubMed ID: 25118597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and bone metabolism pre- and post-kidney transplantation.
    Hamdy NA
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):923-35; viii. PubMed ID: 17983929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone metabolism alterations after kidney transplantation].
    Torres A; García S; Barrios Y; Hernández D; Lorenzo V
    Nefrologia; 2003; 23 Suppl 2():122-6. PubMed ID: 12778868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone disease in post-transplant patients.
    Jeon HJ; Kim H; Yang J
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):452-8. PubMed ID: 26512770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney transplantation: prevention and treatment for bone loss after transplantation].
    Kokado Y
    Clin Calcium; 2006 Jan; 16(1):86-91. PubMed ID: 16397356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis after solid organs transplantation].
    Cipriani R; Farias ML
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):369-77. PubMed ID: 16543990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
    Tokumoto T; Tanabe K; Toma H; Akiba T
    Clin Calcium; 2004 May; 14(5):710-8. PubMed ID: 15577031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Grade Persistent Hyperparathyroidism After Pediatric Renal Transplant.
    Gulleroglu K; Baskin E; Moray G; Haberal M
    Exp Clin Transplant; 2016 Jun; 14(3):294-8. PubMed ID: 26581346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
    Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
    Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic bone disease after renal transplantation.
    Haffner D; Schüler U
    Curr Opin Pediatr; 2014 Apr; 26(2):198-206. PubMed ID: 24535492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis after organ transplantation.
    Rodino MA; Shane E
    Am J Med; 1998 May; 104(5):459-69. PubMed ID: 9626030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.